Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06597630 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Pathological Type，Gene Mutation and Clinical Characteristics of Unilateral Primary Aldosteronism

StatusUnknown
PhaseNot specified
SponsorQifu Li
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 19, 2024 (before its estimated October 31, 2024 completion). Its status may not reflect the trial's current state.

Record History

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Recruiting
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Qifu Li
6 trials monitored
See all monitored trials
1. Aim to investigate the pathological feature of UPA in Asians 2. To clarify the relationship between pathology, clinical phenotype, genetic mutation and surgical outcome of UPA in Asians. 3. To explore a new pathological type of unilateral primary aldosterone
Trial Details
NCT Number NCT06597630
Lead Sponsor Qifu Li
Conditions
(from sponsor)		 Primary Aldosteronism
Related terms Hyperaldosteronism
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov